Cafepharma Today

April 14 2025 - Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan
Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan
FDA after the storm: drug review delays and increased executive oversight expected
In short reprieve for pharma, commerce secretary says drug tariffs to come 'in the next month or two'
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA approves first-of-its-kind RNA drug for hemophilia
BioPharma Dive
Sunday, March 30, 2025 - 10:26pm
tags:
Sanofi, FDA, fitusiran, Qfitlia, hemophilia
Senate investigation claims Pfizer shifted profits offshore in what could be pharma's 'largest tax-dodging scheme'
Fierce Pharma
Friday, March 28, 2025 - 11:29am
tags:
Senate, Pfizer, offshoring
FDA declines to approve Milestone's heart rhythm nasal spray
MSN/Reuters
Friday, March 28, 2025 - 11:27am
tags:
FDA, Milestone Pharmaceuticals, Cardamyst
Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide
Fierce Biotech
Friday, March 28, 2025 - 11:24am
tags:
Lexicon Pharmaceuticals, Novo Nordisk, obesity, semaglutide
BofA cuts Novo Nordisk shares target on expected Q1 earnings miss
Yahoo Finance
Friday, March 28, 2025 - 11:22am
tags:
Novo Nordisk, earnings, Wegovy, Ozempic
DBV Technologies announces up to $307M financing to advance Viaskin Peanut program
MSN/Seeking Alpha
Friday, March 28, 2025 - 11:20am
tags:
DBV Technologies, funding, peanut allergy, Viaskin Peanut
CRISPR Therapeutics COO Departure Announced Following 7% Share Price Decline
Yahoo Finance
Friday, March 28, 2025 - 11:18am
tags:
CRISPR Therapeutics, Julianne Bruno, CRISPR
Langer spin-out Lyndra Therapeutics begins winding down operations, lays off staff
Fierce Biotech
Friday, March 28, 2025 - 11:16am
tags:
Lyndra Therapeutics, Robert Langer, layoffs
Prepared, not panicked: Leaders await RFK Jr.’s potential TV pharma ad ban
Medical Marketing and Media
Friday, March 28, 2025 - 11:15am
tags:
pharma ads, DTC ads, television ads, HHS, Robert F Kennedy Jr.
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
Fierce Biotech
Friday, March 28, 2025 - 11:14am
tags:
BioNTech, small cell lung cancer, bispecific antibodies, BNT327
European committee says Lilly Alzheimer's drug shouldn't get marketing approval
Yahoo/AP
Friday, March 28, 2025 - 11:13am
tags:
Eli Lilly, Kisunla, Europe, Alzheimer's disease, EMA
New Chan Zuckerberg biohub to focus on cells' inner workings
Axios
Friday, March 28, 2025 - 11:11am
tags:
biotech, imaging, Mark Zuckerberg, Priscilla Chan, California
Chiesi backs growth plans with a €430m new plant in Italy News
Pharmaphorum
Friday, March 28, 2025 - 11:09am
tags:
The Chiesi Group, Italy, drug manufacturing
Trump tariff threats prompt some drugmakers to expedite shipments to US
MSN/Reuters
Thursday, March 27, 2025 - 10:47pm
tags:
tariffs, drug importation, Donald Trump
GSK tip claiming Pfizer delayed COVID vaccine results during 2020 election prompts US probe
Fierce Pharma
Thursday, March 27, 2025 - 10:42pm
tags:
GSK, Pfizer, COVID-19, vaccines, legal, 2020 Presidential election
Lilly adds Alzheimer’s disease care to DTC telehealth platform
Fierce Pharma
Thursday, March 27, 2025 - 10:40pm
tags:
Eli Lilly, LillyDirect, DTC, Alzheimer's disease
Abbott Takes on Medtronic, Boston Sci, J&J in PFA Space
Medical Devices and Diagnostics Industry
Thursday, March 27, 2025 - 10:39pm
tags:
Abbott Labs, Medtech, PFA, Volt PFA, atrial fibrillation
RFK Jr. prepares 10,000 more job cuts across HHS, outlines office consolidations
Fierce Healthcare
Thursday, March 27, 2025 - 11:40am
tags:
HHS, regulatory, Robert F Kennedy Jr., DOGE
Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme
Fierce Pharma
Thursday, March 27, 2025 - 11:39am
tags:
Merck, Keytruda, non-small cell lung cancer
Dexcom’s FDA warning letter reveals unauthorized changes to sensors
Medtech Dive
Thursday, March 27, 2025 - 11:18am
tags:
Medtech, DexCom, continuous glucose monitoring, diabetes, CGMs, FDA

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline
Metallic Flatland
In the Pipeline
The Continuing Crisis, Part XI: Feral Children, Breaking Things
In the Pipeline
Methyl Groups Will Always Be Magic
In the Pipeline
Predicting Picky Protein Interactions
In the Pipeline
The Continuing Crisis, Part X: Reductions in Force, Gains in Centralized Power
In the Pipeline
A New Pan-Coronovirus Protease Inhibitor Possibility
In the Pipeline
Pain Continues to Be a Pain
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.